Identifying biomarkers from mass spectrometry data with ordinal outcome

Cancer Informatics

Volumn 3, Issue , 2007, Pages 19-28

  Kwon, Deukwoo ^a   Tadesse, Mahlet G ^b   Sha, Naijun ^c   Pfeiffer, Ruth M ^a   Vannucci, Marina ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TEXAS AT EL PASO   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Markov chain Monte Carlo; Mass spectrometry; Ordinal outcome; Variable selection

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN;

ACCURACY; ARTICLE; BAYES THEOREM; CANCER GRADING; CONTROLLED STUDY; FEMALE; HUMAN; MASS SPECTROMETRY; METHODOLOGY; NORMAL HUMAN; OUTCOME ASSESSMENT; OVARY CANCER; PREDICTION; STATISTICS; STOCHASTIC MODEL; CANCER CLASSIFICATION; CLINICAL ARTICLE; CLINICAL FEATURE;

EID: 34447573031     PISSN: 11769351     EISSN: 11769351     Source Type: Journal    
DOI: 10.1177/117693510700300024     Document Type: Article

References (24)

1. Petricoin, E.F., Ardekani, A.M., Hitt, B.A., Levine, P.J., Fusaro, V.A., Steinberg, S.M., Mills, G.B., Simone, C., Fishman, D.A., Kohn, E.C. and Liotta. L.A. 2002.Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359:572-577.
2. Brown, M.P., Grundy, W.N., Lin, D., Cristianini, N., Sugnet, C.W., Furey, T.S., Ares, M. and Haussler, D. 2000. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc. Natl. Acad. Sci. U.S.A., 97:262-267.
3. Tibshirani, R., Hastie, T., Narasimhan, B. and Chu. G. 2002. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. U.S.A., 99:6567-6572.
4. Sha, N., Vannucci, M., Tadesse, M.G., Brown, P.J., Dragoni, I., Davies, N., Roberts, T., Contestabile, A., Salmon, M., Buckley, C. and Falciani. F. 2004. Bayesian variable selection in multinomial probit models to identify molecular signatures of disease stage. Biometrics, 60:812-819.
5. Chu, W., Ghahramani, Z., Falciani, F. and Wild, D.L. 2005. Biomarker discovery in microarray gene expression data with Gaussian processes. Bioinformatics, 21:3385-3393.
6. Moore, L.E., Fung, E.T., McGuire, M., Rabkin, C.C., Molinaro, A., Wang, Z.F., Zhang, J., Wang, C., Yip, Meng, X.Y. and Pfeiffer, R.M. 2006. Evaluation of apolipoproteina1 and post-translationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population. Cancer Epidemiology Biomarkers & Prevention, 15:1641-1646.
7. Cannistra, S.A. 2004. Cancer of the ovary. N. Engl. J. Med., 351:2519-2529.
8. Cohen, L.S., Escobar, P.F., Scharm, C. Glimco, B. and Fishman, D.A. 2001. Three dimensional power doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction. Gynecol. Oncol., 82:40-48,
9. Zhang, Z., Bast, R.C., Yu, Y., Li, J., Sokoll, L.J., Rai, A.J., Rosenzweig, J.M., Cameron, B., Wang, Y.Y., Meng, X.Y., Berchuck, A., Van Haaften Day, C., Hacker, N.F., de Bruijn, H.W., van der Zee, A.G., Jacobs, I.J., Fung, E.T. and Chan, D.W. 2004. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res., 64:5882-5890.
10. Coombes, K.R., Fritsche, H.A., Clarke, C. Chen, J.N., Baggerly, K.A., Morris, J.S., Xiao, L.C., Hung, M.C. and Kuerer, H.M. 2003. Quality control and peak .nding for proteomics data collected from nipple aspirate fluid by surface enhanced laser desorption and ionization. Clinical Chemistry, 49:1615-1623.
11. Qu, Y., Adam, B.L., Thornquist, M., Potter, J.D., Thompson, M.L., Yasui, Y., Davis, J., Schellhammer, P.F., Lisa Cazares, and M.A. et al. 2003. Clements. Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data. Biometrics, 59:143-151.
12. Randolph T.W. and Tasui, Y. 2006. Multiscale processing of mass spectrometry data. Biometrics, 62:589-597.
13. DiMagno, E.P., Corle, D., O'Brien, J.F., Masnyk, I.J., Go, V.L.W. and Aamodt, R. 1989. Effect of longterm freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin. Proc., 64:1226-1234.
14. Donoho, D.L. and Johnstone, I.M. 1994. Ideal spatial adaption by wavelet shrinkage. Biometrika., 81:425-455.
15. Morris, J., Coombes, K., Koomen, J., Baggerly, K. and Kobayasi, R. 2005. Feature extraction and quantification for mass spectrometry data in biomedical application using the mean spectrum. Bioinfor matics, 21:1764-1775.
16. Percival, D.B. and Walden, A.T. 2000. Wavelet Methods for Time Series Analysis. Cambridge University Press, Cambridge, U.K.
17. Albert, J.H. and Chib, S. 1993. Bayesian analysis of binary and polychotomous response data. J Am. Stat. Assoc., 88:669-679.
18. Brown, P.J., Vannucci, M. and Fearn, T. 2002. Bayes model averaging with selection of regressors. J. R. Stat. Soc., Ser. B., 64:519-536.
19. Lindley, D.V. 1957. A statistical paradox. Biometrika., 44:187-192.
20. Gelfand. A.E. 1996. Model determination using sampling-based methods. In Gilks, W.R., Richardson, S. and Spiegelhalter, D.J. editors, Markov Chain Monte Carlo in Practice, p. 145-162. London: Chapman & Hall.
21. Molinaro, A.E., Simon, R. and Pfeiffer, R.M. 2005. Prediction error estimation: a comparison of resampling methods. Bioinformatics, 21:3301-3307.
22. Fong, E.T., Yip, T.T., Lomas, L., Wang, Z., Yip, C., Meng, X.Y., Lin, S., Zhang, F., Zhang, Z., Chan, D.W. and Weiberger, S.R. 2005. Classification of cancer types by measuring variants of host response proteins using seldi serum assays. Int. J. Cancer, 115:783-789.
23. Song, J., Patel, M., Rosenzweig, C.N., Yee, C.L., Sokoll, L.J., Fung, E.T., Choi-Miura, N.H., Goggins, M., Chan D.W. and Zhang, Z. 2006. Quantification of fragments of human serum inter-α-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionizationbased immunoassay. Clinical Chemistry, 52:1045-1053.
24. Cai. T.T. 1999. Adaptive wavelet estimation: a block thresholding and oracle ine ality approach. Annals of Statistics, 27:898-924.